Market closed
Enzo Biochem/ENZ
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Enzo Biochem
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Ticker
ENZ
Sector
Trading on
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
185
Website
Enzo Biochem Metrics
BasicAdvanced
$58M
Market cap
1.26
P/E ratio
$0.89
EPS
0.78
Beta
-
Dividend rate
Price and volume
Market cap
$58M
Beta
0.78
52-week high
$1.50
52-week low
$0.99
Average daily volume
60K
Financial strength
Current ratio
3.496
Quick ratio
2.82
Long term debt to equity
4.02
Total debt to equity
10.514
Interest coverage (TTM)
-15.07%
Management effectiveness
Return on assets (TTM)
-12.77%
Return on equity (TTM)
-39.90%
Valuation
Price to earnings (TTM)
1.264
Price to revenue (TTM)
1.694
Price to book
0.83
Price to tangible book (TTM)
0.83
Price to free cash flow (TTM)
-1.307
Growth
Revenue change (TTM)
-204.05%
Earnings per share change (TTM)
-194.91%
3-year revenue growth (CAGR)
-33.32%
3-year earnings per share growth (CAGR)
221.37%
Enzo Biochem Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Enzo Biochem Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Enzo Biochem News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Enzo Biochem stock?
Enzo Biochem (ENZ) has a market cap of $58M as of October 11, 2024.
What is the P/E ratio for Enzo Biochem stock?
The price to earnings (P/E) ratio for Enzo Biochem (ENZ) stock is 1.26 as of October 11, 2024.
Does Enzo Biochem stock pay dividends?
No, Enzo Biochem (ENZ) stock does not pay dividends to its shareholders as of October 11, 2024.
When is the next Enzo Biochem dividend payment date?
Enzo Biochem (ENZ) stock does not pay dividends to its shareholders.
What is the beta indicator for Enzo Biochem?
Enzo Biochem (ENZ) has a beta rating of 0.78. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.